Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
25 Years to 79 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
25 to 79 years old.
Provide voluntary written informed consent to participate.
Smoking history of at least 10 pack years (1 pack of cigarettes per day for 10 years).
Diagnosis of chronic obstructive pulmonary disease.
Become short of breath with physical activity.
Elevated systolic pulmonary artery pressures.
Not pregnant, nursing, or planning a pregnancy.
Left ventricular ejection fraction <30%.
Heart attack or stroke within the last 6 months.
History of lung resection surgery.
Use of supplemental oxygen >20 hours/day.
Blood donation or significant blood loss within the last 56 days.
Plasma donation within the last 14 days.
Use of any drugs for another research study within the last 30 days.
Use of vasodilators, long acting nitrates, prostacyclin analogs, endothelin antagonists, or phosphodiesterase inhibitor drugs within the last 14 days.
Positive blood screen Hepatitis B surface antigen (HBsAg) or Hepatitis C Antibody.
Major surgery within the last 28 days.
Any other medical condition that may jeopardize the safety of the subject, the validity of the study results, or interfere with the completion of the study according to the protocol.